I agree that this site is using cookies. You can find further informations here.
X
Katrijn Broos
38  results:
Search for persons X
?
1

Real Time, Point-of-Need Measurement of Blood CD19 CAR-T Ve..:

Bharadwaj, Sushma ; Smith, Courtney J ; Nater, Jenny...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S209 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Nanobody-mediated SPECT/CT imaging reveals the spatiotempor..:

Ertveldt, Thomas ; Meulewaeter, Sofie ; De Vlaeminck, Yannick...
Theranostics.  13 (2023)  15 - p. 5483-5500 , 2023
Link: https://doi.org/10.7150/..
 
?
3

Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic C..:

Kalus, Philipp ; De Munck, Jolien ; Vanbellingen, Sarah...
International Journal of Molecular Sciences.  23 (2022)  9 - p. 4865 , 2022
Link: https://doi.org/10.3390/..
 
?
4

Formatting and gene-based delivery of a human PD-L1 single ..:

Awad, Robin Maximilian ; Lecocq, Quentin ; Zeven, Katty...
Molecular Therapy - Methods & Clinical Development.  22 (2021)  - p. 172-182 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validatio..:

Bridoux, Jessica ; Broos, Katrijn ; Lecocq, Quentin...
Biomolecules.  10 (2020)  10 - p. 1388 , 2020
Link: https://doi.org/10.3390/..
 
?
6

Evaluating a Single Domain Antibody Targeting Human PD-L1 a..:

Broos, Katrijn ; Lecocq, Quentin ; Xavier, Catarina...
Cancers.  11 (2019)  6 - p. 872 , 2019
Link: https://doi.org/10.3390/..
 
?
7

Single Domain Antibody-Mediated Blockade of Programmed Deat..:

Broos, Katrijn ; Lecocq, Quentin ; Keersmaecker, Brenda De...
Vaccines.  7 (2019)  3 - p. 85 , 2019
Link: https://doi.org/10.3390/..
 
?
8

Impact of lenalidomide maintenance on the immune environmen..:

Fostier, Karel ; Caers, Jo ; Meuleman, Nathalie...
Oncotarget.  9 (2018)  29 - p. 20476-20489 , 2018
Link: https://doi.org/10.18632..
 
?
9

Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong..:

Van der Jeught, Kevin ; De Koker, Stefaan ; Bialkowski, Lukasz...
ACS Nano.  12 (2018)  10 - p. 9815-9829 , 2018
Link: https://doi.org/10.1021/..
 
?
10

Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Em..:

Broos, Katrijn ; Lecocq, Quentin ; Raes, Geert...
Theranostics.  8 (2018)  13 - p. 3559-3570 , 2018
Link: https://doi.org/10.7150/..
 
?
11

A versatile T cell-based assay to assess therapeutic antige..:

Versteven, Maarten ; Van den Bergh, Johan M.J. ; Broos, Katrijn...
Oncotarget.  9 (2018)  45 - p. 27797-27808 , 2018
Link: https://doi.org/10.18632..
 
?
12

Non-invasive assessment of murine PD-L1 levels in syngeneic..:

Broos, Katrijn ; Keyaerts, Marleen ; Lecocq, Quentin...
Oncotarget.  8 (2017)  26 - p. 41932-41946 , 2017
Link: https://doi.org/10.18632..
 
?
13

Particle-mediated Intravenous Delivery of Antigen mRNA Resu..:

Broos, Katrijn ; Van der Jeught, Kevin ; Puttemans, Janik...
Molecular Therapy - Nucleic Acids.  5 (2016)  - p. e326 , 2016
Link: https://doi.org/10.1038/..
 
?
14

The transduction pattern of IL‐12‐encoding lentiviral vecto..:

Goyvaerts, Cleo ; Broos, Katrijn ; Escors, David...
European Journal of Immunology.  45 (2015)  12 - p. 3351-3361 , 2015
Link: https://doi.org/10.1002/..
 
?
15

Targeting the tumor microenvironment to enhance antitumor i..:

Van der Jeught, Kevin ; Bialkowski, Lukasz ; Daszkiewicz, Lidia...
Oncotarget.  6 (2014)  3 - p. 1359-1381 , 2014
Link: https://doi.org/10.18632..
 
1-15